Comment
doi: 10.1001/jamanetworkopen.2021.11156.
Nonrandomized Comparison of Adverse Events Following Facility- and Home-Infused Biologics Using Real-World Data
Affiliations
- PMID: 34081142
- DOI: 10.1001/jamanetworkopen.2021.11156
Item in Clipboard
Comment
Nonrandomized Comparison of Adverse Events Following Facility- and Home-Infused Biologics Using Real-World Data
JAMA Netw Open.
.
Free article
No abstract available
Comment on
-
Comparison of Adverse Events Among Home- vs Facility-Administered Biologic Infusions, 2007-2017.JAMA Netw Open. 2021 Jun 1;4(6):e2110268. doi: 10.1001/jamanetworkopen.2021.10268. JAMA Netw Open. 2021. PMID: 34081140 Free PMC article.
Similar articles
-
Use of biologics in a patient with rheumatoid arthritis refractory to methotrexate.CMAJ. 2013 Jun 11;185(9):793-5. doi: 10.1503/cmaj.121607. Epub 2013 Mar 4. CMAJ. 2013. PMID: 23460636 Free PMC article. No abstract available.
-
Safety of Biologic Agents in Elderly Patients with Rheumatoid Arthritis.J Rheumatol. 2016 Nov;43(11):1984-1988. doi: 10.3899/jrheum.160012. Epub 2016 Sep 1. J Rheumatol. 2016. PMID: 27585685
-
End-Stage Rheumatoid Arthritis in the Era of Biologics.J Clin Rheumatol. 2024 Mar 1;30(2):e71. doi: 10.1097/RHU.0000000000002059. Epub 2024 Jan 6. J Clin Rheumatol. 2024. PMID: 38190752 No abstract available.
-
[Safety of biologic therapy - results from the German biologics register RABBIT].Dtsch Med Wochenschr. 2014 Sep;139(37):1817-20. doi: 10.1055/s-0034-1370252. Epub 2014 Sep 2. Dtsch Med Wochenschr. 2014. PMID: 25180996 Review. German. No abstract available.
-
Rheumatoid arthritis.Foot Ankle Clin. 2007 Sep;12(3):525-37, vii. doi: 10.1016/j.fcl.2007.04.004. Foot Ankle Clin. 2007. PMID: 17765843 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
